Leap Therapeutics Inc.

NASDAQ: LPTX · Real-Time Price · USD
0.42
0.03 (6.87%)
At close: Jun 09, 2025, 3:59 PM

Leap Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.6 -1.04 -0.93 -6.85
PEG Ratio
0.03 0.06 -0.49 -3.53
PS Ratio
n/a n/a n/a 185.38
PB Ratio
3.09 1.41 0.87 2.58
P/FCF Ratio
-1.79 -1.93 -1.04 -7.91
P/OCF Ratio
-1.79 -1.93 -1.04 -7.91
OCF/S Ratio
n/a n/a n/a -23.44
Debt / Equity Ratio
0.01 0.00 0.01 0.00
Quick Ratio
3.41 5.64 6.05 11.70
Current Ratio
3.41 5.64 6.05 11.70
Asset Turnover
n/a n/a n/a 0.01
Interest Coverage
n/a n/a -1.05K -1.01K
Return on Equity
-1.93 -1.35 -0.93 -0.38
Return on Assets
-1.38 -1.12 -0.78 -0.34
Return on Invested Capital
-2 -1.44 -0.95 -0.38
Dividend Yield
0.00 n/a n/a n/a
Payout Ratio
-0.00 n/a n/a n/a
Gross Profit Margin
n/a n/a n/a 1.00
Net Profit Margin
n/a n/a n/a -27.06
Pretax Profit Margin
n/a n/a n/a -27.07
Operating Profit Margin
n/a n/a n/a -27.62
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a -26.68